Sodium Glucose Co-transporter-2 Inhibitor: Benefits beyond Glycemic Control

Type 2 diabetes mellitus (T2DM) is a family of metabolic disorders characterized by hyperglycemia as a consequence of abnormalities in insulin secretion and insulin sensitivity. It affects hundreds of millions of people worldwide and leads to increased morbidity, compromised quality of life, higher...

Descripción completa

Detalles Bibliográficos
Autores principales: Baruah, Manash Pratim, Makkar, B. M., Ghatnatti, Vikrant B., Mandal, Kaushik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446679/
https://www.ncbi.nlm.nih.gov/pubmed/31016169
http://dx.doi.org/10.4103/ijem.IJEM_160_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446679/
https://www.ncbi.nlm.nih.gov/pubmed/31016169
http://dx.doi.org/10.4103/ijem.IJEM_160_17

Ejemplares similares